HOTH vs NWSA · rev $1.24B vs rev $9.03B
Hoth Therapeutics Inc (HOTH) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
NWSA (NWSA) common stock.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
HOTH currently screens at market cap $15.5M. NWSA currently screens at market cap $0.
Not investment advice. Open the HOTH and NWSA stock pages for the full models.
Not investment advice.